| [1] |
何小华. 炎症性肠病发病的相关免疫机制[J]. 南昌大学学报(医学版), 2011, 51(10): 93-96.
|
| [2] |
Pichai MV,Ferguson LR. Potential prospects of nanomedicine for targeted therapeutics in inflammatory bowel diseases[J]. World J Gastroenterol, 2012, 18(23): 2895-2901.
|
| [3] |
江学良. 溃疡性结肠炎现代治疗诊疗手册[M]. 北京: 中国医药科技出版社, 2006: 81-90.
|
| [4] |
Ding HG,Shan J,Zhang B, et al. Combined human growth hormone and lactulose for prevention and treatment of multiple organ dysfunction in patients with severe chronic hepatitis B[J]. World J Gastroenterol, 2005, 11(19): 2981-2983.
|
| [5] |
郭光华,蔡晨,李国辉, 等. 肠内免疫营养联合重组人生长激素对烫伤大鼠的治疗作用[J]. 中国危重病急救医学, 2006, 18(1): 42-45.
|
| [6] |
王兴鹏,王冰娴,吴建新, 等. 生长激素对实验性急性坏死性胰腺炎肠道细菌移居的影响[J]. 中华消化杂志, 2000, 20(3): 171-174.
|
| [7] |
Scopa CD,Koureleas S,Tsamandas AC, et al. Beneficial effects of growth hormone and insulin-like growth factor 1 on intestinal bacterial translocation, endotoxemia, and apoptosis in experimentally jaundiced rats[J]. J Am Coll Surg, 2000, 190(4): 423-431.
|
| [8] |
Yang ZW,Li JG,Mao XG, et al. Effects of recombinant human growth hormone on intestinal translocation of bacteria and endotoxin in rats with obstructive jaundice[J]. Hepatobiliary Pancreat Dis Int, 2005, 4(3): 445-449.
|
| [9] |
黄英,王树人,应明英, 等. 重组人生长激素对败血症大鼠的实验治疗[J]. 中国病理生理杂志, 2003, 19(9): 1253-1256.
|
| [10] |
Han X,Sosnowska D,Bonkowski EL, et al. Growth Hormone Inhibits Signal Transducer and Activator of Transcription 3 Activation and Reduces Disease Activity in Murine Colitis[J]. Gastroenterology, 2005, 129(1): 185-203.
|
| [11] |
Kara E,Sungurtekin H,Sungurtekin U, et al. The effect of recombinant human growth hormone (rhGH) on trinitrobenzene sulfonic acid-induced colitis in rats. An experimental study[J]. Inflamm Bowel Dis, 2004, 10(2): 112-115.
|
| [12] |
Coburn L A,Gong X,Singh K, et al. L-arginine supplementation improves responses to injury and inflammation in dextran sulfate sodium colitis[J]. Plos One, 2012, 7(3): e33546.
|
| [13] |
秦爽,贺育兰,杨静, 等. 重组人生长激素对内毒素诱导人巨噬细胞产生TNF-α、IL-1β含量的影响[J]. 中国感染控制杂志, 2008, 7(1): 9-11.
|
| [14] |
Goh KL,Xiao SD. Inflammatory bowel disease: A survey of the epidemiology in Asia[J]. J Dig Dis, 2009, 10(1): 1-6.
|
| [15] |
尹岸民. 溃疡性结肠炎患者血浆炎性反应细胞因子水平的变化[J]. 吉林医学, 2011, 32(27): 5682-5682.
|
| [16] |
Owczarek D,Cibor D,Głowacki MK, et al. TNF-α and soluble forms of TNF receptors 1 and 2 in the serum of patients with Crohn′s disease and ulcerative colitis[J]. Pol Arch Med Wewn, 2012, 122(12): 616-623.
|
| [17] |
Coccia M,Harrison OJ,Schiering C, et al. IL-1β mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4＋Th17 cells[J]. J Exp Med, 2012, 209(9): 1595-1609.
|
| [18] |
朱向东,曹燕飞,王燕, 等. 溃疡性结肠炎大鼠血清白细胞介素-1β、肿瘤坏死因子-α、白细胞介素-4动态表达规律[J]. 中国老年学杂志, 2015, 35(2): 410-412.
|
| [19] |
唐月华,王小平. 溃疡性结肠炎患者血清IL-1β和IL-18的表达及临床意义[J]. 河北医药, 2015, 37(10): 1534-1535.
|